Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 33 - Medicinal preparations containing inorganic active ingredients
Patents for A61K 33 - Medicinal preparations containing inorganic active ingredients (56,213)
04/2003
04/03/2003US20030062043 Method and apparatus for nitric oxide generation
04/03/2003CA2464436A1 Method and topical formulation for treating skin conditions associated with aging
04/03/2003CA2461219A1 Reduced toxicity cisplatin formulations and methods for using the same
04/03/2003CA2461140A1 Inactivation of papillomavirus
04/03/2003CA2460344A1 Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
04/02/2003EP1296667A2 Use of an aluminium and ethylenediamine-tetraacetic complex for preventing and/or treating urticaria
04/02/2003EP1296639A1 Cosmetic and pharmaceutical compositions and methods using green-light emitting materials
04/02/2003EP1143799B1 Multi-purpose acid compositions
04/02/2003EP1083886B1 Drug delivery system comprising a tightly compacted solid medicament stock
04/02/2003EP0858326B1 Non-aqueous colonic purgative formulations
04/02/2003CN1406621A Medicines for treating psoriasis
04/02/2003CN1406615A Medicine against for beriberi and sore and boil
04/02/2003CN1406599A Process for producing medicine or health-care food from abalone shells
04/02/2003CN1406598A Oral cavity ulcer powder and preparation thereof
04/02/2003CN1406587A Use of activated carbon in oral medicinal preparation for hyperthyroidism
04/02/2003CN1104378C Fine cisplatin powder and process for production thereof
04/02/2003CN1104248C Chinese medicine for treating tuberculosis and hepatitis
04/02/2003CN1104247C Suppository for treating cervical erosion and vaginitis
04/02/2003CN1104246C Fumigant lotion for treating anorectal disease and preparing process thereof
04/02/2003CN1104244C Use of physiologically acceptable vanadium compounds, salts and compelxes
04/02/2003CN1104236C 一种治疗胃病的口服液 A treatment for stomach oral
04/02/2003CN1104233C Spot-eliminating and beautifying cream
04/01/2003US6541680 Mixture of choline, betaine, folic acid, vitamin B12, methionine and zinc
04/01/2003US6541518 Preventing pathogens in blood plasma and for enhancing the production of cryoprecipitate from plasma by adding a low molecular weight carboxylic acid or salt to the plasma, preferably trisodium citrate
04/01/2003US6541508 Water solubility; prodrug containing polyether oligomer
04/01/2003US6541490 Treating ischemia or reoxygenation injury; preparation from a bipyridine, a benzeneboronic acid and a manganese salt
04/01/2003US6541163 Process of powder for bath from natural plants
04/01/2003US6541048 Coated chewing gum products containing an acid blocker and process of preparing
04/01/2003US6541043 Method and synergistic composition for treating attention deficit/hyperactivity disorder
04/01/2003US6541040 Mixture consists of paraffins or synthetic waxes selected from montan waxes, petroleum waxes, Fischer-Tropsch waxes, polyolefin waxes, petrolatum waxes, wax alcohol and oxidates and atleast one alkali or alkaline hydroxide
04/01/2003US6541000 Hydroxyapatite-antigen conjugates and methods for generating a poly-Ig immune response
04/01/2003CA2239423C Compositions, containing bismuth and one or more antimicrobials, for the prevention and treatment of gastrointestinal disorders
04/01/2003CA2163539C N-morpholino-n-nitrosaminoacetonitrile cyclodextrin inclusion complexes
03/2003
03/27/2003WO2003025571A1 Diagnostic markers for ischemia
03/27/2003WO2003025119A2 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
03/27/2003WO2003024950A1 Coumarin derivative
03/27/2003WO2003024467A1 Compositions containing specific plants and drugs and foods for health use comprising the compositions as the active ingredient
03/27/2003WO2003024459A1 Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents
03/27/2003WO2003024449A1 Pharmaceutical formulations for protecting pharmaceutical compound from acidic environments
03/27/2003WO2002078678A3 Methods of treating cancer using cyplastin combined with a dioxolane nucleoside such as troxacitabine
03/27/2003WO2002026219A3 Otic microbial combinations for treatment of animals with ruptured tympanic membrane
03/27/2003US20030060434 Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
03/27/2003US20030059484 Cosmetic treatment method for fighting against skin ageing effects
03/27/2003US20030059481 Composition for promoting healthy bone structure
03/27/2003US20030059478 Aqueous extract of the plant Soma; a mixture of milk, plant derivatives and a mineral comprising apple cider vinegar, quinine, blackstrap molasses, sulfur and whole milk; anticarcinogenic and -tumor agents
03/27/2003US20030059457 Phaseolamin compositions and methods for using the same
03/27/2003US20030059450 Anti-aging formulation containing a cosmeceutically active base, which is a hydroxide- releasing inorganic or nitrogen containing organic base, the formulation has a pH in the range of about 7.5 to 13.0
03/27/2003US20030059403 Phaseolamin compositions and methods for using the same
03/27/2003US20030059375 Method for treating lung cancers
03/27/2003US20030059368 Chelator noncovalently bonded to a stable isotope having a nucleus capable of capturing a neutron and emitting a photon, a counterion and a buffer; measuring glomerular filtration rate and glomerular sieving function in a subject
03/27/2003CA2460987A1 Pharmaceutical formulations for protecting pharmaceutical compound from acidic environments
03/27/2003CA2460620A1 Protopanaxadiol and protopanaxatriol and their use as synergistic anti-cancer agents
03/27/2003CA2456193A1 Compositions comprising immunostimulatory oligonucleotides and uses thereof to enhance fc receptor-mediated immunotherapies
03/27/2003CA2425784A1 Diagnostic markers for ischemia
03/26/2003EP1296142A2 Calcium receptor active molecules
03/26/2003EP1295607A1 Antitumor effect potentiators
03/26/2003EP1295602A1 Oxygen-containing ophthalmic composition
03/26/2003EP1295597A1 Antitumour compositions containing taxan derivatives
03/26/2003EP1295535A2 Phaseolamin compositions and methods for using the same
03/26/2003EP1294922A2 Method for treating cancer, visualizing cell structures, and isolating organelles using organelle crystallizing agents
03/26/2003EP1294732A1 Ruthenium (ii) compounds for use in the therapy of cancer
03/26/2003EP1294422A1 Methods and systems for enhancing fluid flow through an obstructed vascular site
03/26/2003EP1294384A2 Use of lanthanum compounds for the treatment of bone diseases
03/26/2003EP1294383A2 Oral compositions comprising antimicrobial agents
03/26/2003EP1294347A2 Oral care compositions comprising chlorite
03/26/2003EP1294345A2 Promoting whole body health
03/26/2003EP1119366B1 Animal stereotypy
03/26/2003CN1406140A Nano capsule encapsulation system and method
03/26/2003CN1406131A Sympathetic-activating perfume composition
03/26/2003CN1404841A Novel use of iodine tincture in treating tumor medicine
03/26/2003CN1103750C Bioactive glass composltions and method of treatment using bioactive glass
03/26/2003CN1103594C Application of injection for treating thrombocyto penic purpura
03/26/2003CA2405378A1 Stable taurolidine electrolyte solutions
03/25/2003US6538037 Inhibiting the hyperproliferation of malignant or neoplastic cells by treating the cells with an antiproliferative amount of 1 alpha ,24(S)-dihydroxyvitamin D2 the cells being cancers of the lung, neck and head, pancreas, endometrium, bladder
03/25/2003US6538036 Method for preventing and treating peripheral neuropathy by administering selegiline
03/25/2003US6538026 A composition comprising of a monomer component comprised of at least one alkyl cyanoacrylate and at least one inhibitor, and a second component comprised of a resultant aggregate structure formed from an alkyl cyanoacrylate monomer, an alkyl
03/25/2003US6537990 Combined preparations comprising morpholine anthracyclines and anticancer agent
03/25/2003US6537982 Method of treating prostatic diseases using active vitamin D analogues
03/25/2003US6537820 Method for producing purified hematinic iron-saccharidic complex and product produced
03/25/2003US6537590 Solution and the method of making the same for the treatment of osteoarthritis
03/25/2003US6537589 Calcium phosphate artificial bone as osteoconductive and biodegradable bone substitute material
03/25/2003US6537581 Compositions and methods for treating eye discomfort
03/20/2003WO2003022292A1 Oral pharmaceutical formulation containing active carbon and use of the same
03/20/2003WO2003022282A1 Use of 4-pyridylmethylphthalazines for cancer treatment
03/20/2003WO2003022268A1 A combination and method of treatment of cancer utilizing a cox-2 inhibitor and a 3-hydroxy-3-methylglutaryl-coenzyme-a (hmg-coa) reductase inhibitor
03/20/2003WO2003022264A1 Paclitaxel mixed composition and water-in-oil type emulsion formulation for chemoembolization and preparation method thereof
03/20/2003WO2002092042A3 Pharmaceutical and cosmetic compositions against skin aging
03/20/2003WO2002066040A8 Sensitization of chemotherapeutic agent resistant neoplastic cells with reovirus
03/20/2003WO2002023993B1 Method and composition for the generation of chlorine dioxide using iodo-compounds, and methods of use
03/20/2003WO2001072341A3 Methods of treating neoplasia with combinations of target cell-specific adenovirus, chemotherapy and radiation
03/20/2003US20030055106 Using potassium bisperoxo(1,10-phenanthroline)oxovanadate, potassium bisperoxo(pyridine-2-carboxylato) oxovanadate and potassium bisperoxo(2,2'-bipyridyl) oxovanadate for preventing or arresting angiogenesis in animals
03/20/2003US20030055024 Administering in divided doses an effective amount of a vascular damaging agent or a pharmaceutically acceptable salt thereof for production of a vascular damaging effect in a warm-blooded animal such as a human
03/20/2003US20030055009 Administering a drug for stimulating hair growth, preventing hair loss, or retarding hair loss in a mammal
03/20/2003US20030054058 Vitex agnus castus extract
03/20/2003US20030054046 Hydrated dressing containing metal microbiocide
03/20/2003US20030054015 Mixture of vegetable oil, aromatic solvent and caffeine; nerve stimulant perfume
03/20/2003CA2457848A1 Use of 4-pyridylmethylphthalazines for cancer treatment
03/19/2003EP1292295A1 Supplement to enhance fertility
03/19/2003EP1292278A2 Preparations that contain an extract of the plant pistia stratiotes
03/19/2003EP1107766B1 Use of lithium gluconate in the preparation of a medicament for treating herpes and seborrheic dermatitis
1 ... 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 ... 563